Insilico Medicine's ISM0387 Marks a Revolutionary Step for UAE in Drug Development
Insilico Medicine's Groundbreaking Achievement: ISM0387
On April 23, 2026, Insilico Medicine celebrated a significant milestone in the realm of biotechnology by nominating ISM0387, marking it as the first developmental candidate to emerge from the United Arab Emirates (UAE). This remarkable achievement was made possible through a partnership with the Emirates Drug Establishment (EDE) and local entities such as the Abu Dhabi Investment Office (ADIO) and the Department of Health – Abu Dhabi, which are bolstering the country's aspirations to become a global hub for pharmaceutical innovation.
A Testament to Technological Advancement
For its 30th Preclinical Candidate (PCC) anniversary, the announcement of ISM0387 highlights a major leap in the UAE's drug discovery capabilities, reinforcing the nation's commitment to a knowledge-based economy, dubbed the
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.